Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02548013
Other study ID # Ain Shams MS PPROM
Secondary ID
Status Recruiting
Phase N/A
First received August 25, 2015
Last updated September 11, 2015
Start date August 2014
Est. completion date July 2016

Study information

Verified date September 2015
Source Ain Shams Maternity Hospital
Contact Dina M Ibrahim
Phone 00201223603223
Email Dr_dinamostafa@hotmail.com
Is FDA regulated No
Health authority Egypt: Ministry of Higher Education
Study type Interventional

Clinical Trial Summary

This study is to compare the maternal and neonatal outcomes in the patients with PPROM who are managed at home versus those managed at hospital, half the patients will be managed at home and the other half will be managed inpatient.


Description:

Now the current practice is to manage patients with PPROM at hospital, however it is not known yet whether this practice is better than outpatient management as regard maternal and neonatal outcome.

There is some recent evidence that home management of PPROM is safe for both mother and neonate, home management is also more convenient with less expenses.


Recruitment information / eligibility

Status Recruiting
Enrollment 560
Est. completion date July 2016
Est. primary completion date June 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

1. PPROM with gestational age between 27 to 34 weeks

2. Cephalic presentation

3. Clear amniotic fluid

4. Oral temperature > 38 C

5. Near distance from the hospital (the patient can reach hospital within one hour )

6. Home environment safe and amenable to rest , availability of family support such as a sister or mother who will help the patient at home .

7. Maternal and fetal condition remain stable after hospitalization for 72 hours

Exclusion Criteria:

1. Patient with equivocal diagnosis of rupture of membranes

2. advanced labor

3. intrauterine infection

4. vaginal bleeding or

5. non reassuring fetal heart rate.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
outpatient management
patients if stable will be discharged to continue treatment at home
Inpatient management
patients will continue there treatment in hospital till delivery

Locations

Country Name City State
Egypt Ain Shams Maternity hospital Cairo Abbasya

Sponsors (2)

Lead Sponsor Collaborator
Ain Shams Maternity Hospital Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary rate occurence of Neonatal sepsis proven neonatal infection with positive blood culture within 48 hours after birth, or culture proven neonatal pneumonia or meningitis 48 hours after delivery Yes
Secondary rate of occurence of Maternal morbidity including chorioamnionitis , endometritis , septicaemia, admission to intensive care unit, organ failure, major postpartum hemorrhage 48 hours after delivery Yes
See also
  Status Clinical Trial Phase
Completed NCT01431248 - PPROM Erythromycin Versus Azithromycin N/A
Active, not recruiting NCT04588220 - Melatonin, Soluble Urokinase-type Plasminogen Activator Receptor, and Orosomucoid 2 Levels in PPROM
Completed NCT02314728 - Cervical Ripening in Premature Rupture of Membranes N/A
Not yet recruiting NCT01152528 - Va-Sense - Bacterial Vaginosis Once A Week Screening And Treatment To Reduce Infective Complications, Abortion And Preterm Delivery In Pregnant Women With Previous Preterm Delivery Phase 3
Completed NCT02702297 - Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes
Not yet recruiting NCT02635451 - The Relation Between Serum Ascorbic Acid Concentration and Preterm Premature Rupture of Membranes N/A
Completed NCT01266928 - Does Vitamins C and E Supplementation of After Preterm Rupture of Membranes Prolong the Duration of Latency? A Prospective Randomized Controlled Study Phase 3
Active, not recruiting NCT04532021 - Matrix Metalloproteinase 14, Neopterin, and Orosomucoid 1 Levels in PPROM
Recruiting NCT01584323 - Pomegranate to Reduce Maternal and Fetal Oxidative Stress and Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of the Membranes N/A
Recruiting NCT00466128 - Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM) Phase 2
Terminated NCT00463736 - Magnesium Sulfate Versus Placebo for Tocolysis in PPROM N/A